Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy

Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy

Abstract Background Bleeding is the most common complication of oral anticoagulants, due to inadequate dosing. Case presentation This report describes the clinical course of a patient who developed severe bleeding under therapy with phenprocoumon, despite an INR in the lower therapeutic range. Strik...

Full description

Bibliographic Details
Main Authors: Nils Mülling, Vivian Rosery, H. Christian Reinhardt, Maher Hanoun
Format: Article
Language:English
Published: BMC 2021-06-01
Series:European Journal of Medical Research
Subjects:
Vitamin K antagonists
Bleeding
Acquired hemophilia
Factor IX mutation
Online Access:https://doi.org/10.1186/s40001-021-00533-7

Similar Items

Similar Items